Program Description & Educational Objectives

In this activity, an expert in hepatology discusses practical perspectives on management of hypervolemic hyponatremia in patients with cirrhosis.

Upon completion of this activity, participants will be able to:

• Describe and/or manage disease complications in cirrhotic patients presenting with hyponatremia
• Determine the eligibility of a given cirrhotic patient with hyponatremia for liver transplant
• Apply evidence-based guidelines on the relative efficacy and safety of therapy for hyponatremia in cirrhosis to point-of-care practice
• Recommend therapeutic strategies for hyponatremia in cirrhosis based on disease severity and determine appropriate interventions for cases that are not resolved with recommended initial management

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, nurses, nurse practitioners, pharmacists and other clinicians involved in the management of hyponatremia.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: November 01, 2011 - October 31, 2012
Time to Complete: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

All faculty AND staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

Course Director and Interviewee

Paul Martin, MD
Professor of Medicine
Chief, Division of Hepatology
University of Miami Miller School of Medicine
Chief, Center for Liver Diseases
University of Miami Hospital and Clinics
Jackson Memorial Hospital
Miami, Florida

Paul Martin, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Bristol-Myers Squibb; Genentech, Inc.; Merck & Co., Inc.; Salix Pharmaceuticals, Inc.; and Vertex Pharmaceuticals Incorporated.
Grant/Research Support from Bristol-Myers Squibb; Genentech, Inc.; Gilead; and Vertex Pharmaceuticals Incorporated.

Content Director

Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca currently has no financial interests/relationships or affiliations in relation to this activity.

All additional planning committee members, PVI, PeerView Institute for Medical Education, Inc. staff, and Purdue University College of Pharmacy staff have no relationships to disclose.

Sponsorship, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

The Purdue University College of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Purdue University Continuing Nursing Education, West Lafayette, IN (ISNA No. CNEP 11-03, Exp. 06/1/2014) is an approved provider of continuing nursing education by the Indiana State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity has been approved for 1.0 contact hour(s).

Pharmacists

Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-11-142-H01-P, 1.0 contact hours (0.1 CEUs).
Release Date: November 01, 2011 Expiration Date: October 31, 2012

This CME/CNE/CPE activity is jointly sponsored by Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.